1 |
Galic S, Oakhilla JS, Steinberga GR (2010): Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316(2): 129-139
DOI
ScienceOn
|
2 |
Steinberg GR, Dyck DJ (2000): Development of leptin resistance in rat doleus muscle in ewsponse to high-fat diets. Am J Physiol 279: E1374-E1382
|
3 |
Steinberg GR, Parolin MI, Higenhauser GJ, Dyck DJ (2002): leptin increase FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192
DOI
|
4 |
Steinberg GR, Smith AC, van Denderen BJW, Chen Z, Murthy S, Campbell DJ, Heigenhauser GJF, Dyck DJ, Kemp BE (2004): AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 89: 4575-4580
DOI
ScienceOn
|
5 |
Vettor R, Milan G, Rossato M, Federspil G (2005): Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 22(2): 3-10
DOI
|
6 |
Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA (2001): Effects of weekly administration opegylated recombinant human Ob protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 74: 426-434
DOI
|
7 |
World Health Organization (1998): Obesity: preventing and managing the global epidemic-report of a who consultation on obesity. pp.7-12, Geneva
|
8 |
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman Ml, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001): The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7(8): 941-946
DOI
ScienceOn
|
9 |
Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S (2003): Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52(10): 1274-1278
DOI
ScienceOn
|
10 |
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000): Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 314(2): 1296-1301
|
11 |
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M (2003): Markers of inflammation and cardiovascular disease: Application to clinical and public health practice:A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107(3): 499-511
DOI
ScienceOn
|
12 |
Pi-Sunyer FX (1993): Medical hazards of oesity. Ann Intern Med 119(2): 655-660
DOI
|
13 |
Rahmouni K, Haynes WG (2004): Leptin and the cardiovascular system. Recent Prog Horm Res 59(1): 225-244
DOI
ScienceOn
|
14 |
Ridker PM, Buring JE, Cook NR, Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107(3): 391-397
DOI
ScienceOn
|
15 |
Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T (2004): Adiponectin as a biomarker of the metabolic syndrome. Circ J 68(11): 975-981
DOI
ScienceOn
|
16 |
Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ (2002): Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87(12): 5662-5667
DOI
ScienceOn
|
17 |
Mattews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985): Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7): 412-419
DOI
ScienceOn
|
18 |
Ministry of Health and Welfare (2008): 2007 National health and nutrition survey report
|
19 |
Ministry of Health and Welfare (2009): 2008 National health and nutrition survey report
|
20 |
Muoio DM, Dohm GL (2002): Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 16(4): 653-66
DOI
ScienceOn
|
21 |
Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I (2006): Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47(6): 1108-1116
DOI
ScienceOn
|
22 |
Matsubara M, Maruoka S, Katayose S (2002): Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87(6): 2764-3769
DOI
ScienceOn
|
23 |
Lee MY, Kim JH (2010): Association of serum lipids and dietary intakes with serum adiponectin level in overweight and obese Korean Women. Korean J Community Nutr 15(1): 27-35
|
24 |
Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002): Adiponectin in essential hypertension. J Nephrol 15(5): 507-511
|
25 |
Mantzoros CS, Williams CJ, Manson JE, Meigs JB, Hu FB (2006): Adherence to the mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 84(2): 328-335
|
26 |
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004): Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24(1): 29-33
DOI
ScienceOn
|
27 |
Kim JI (2010): The association between hs-CRP concentration of blood and metabolic syndrome in the residents of rural community. Korean J Community Nutr 15(6): 796-805
|
28 |
Matsuzawa Y (2010): Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad 86: 131-140
|
29 |
Kadowaki T, Yamauchi T (2005): Adiponectin and adiponectin receptors. Endocrine Reviews 26(3): 439-451
DOI
ScienceOn
|
30 |
Kappes A, Loffler G (2000): Influences of ionomycin, dibutyrylcyclo AMP and tumor necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res 32(11): 548-554
DOI
|
31 |
Kim JY, Shin HW, Jeong IK, Cho SW, Min SJ, Lee SJ, Park CY, Oh KW, Kim HK, Kim DM, Yu JM, Ihm SH, Choi MG, Yoo HJ, Park SW (2005): The relationship of adiponectin, leptin and ghrelin to insulin resistance and cardiovascular risk factors in human obesity. Korean J Med 69(6): 631-641
|
32 |
Hsueh WA, Buchanan TA (1994): Obesity and hypertension. Endocrinol Metab Clin North Am 23(2): 405-427
|
33 |
Koner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W (2007): New predictors of the metabolic syndrome in children role of adipocytokines. Pediatr Res 61(6): 640-645
DOI
ScienceOn
|
34 |
Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y (2003): Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23(1): 85-89
DOI
ScienceOn
|
35 |
Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y (2001): Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50(5): 1126-1133
DOI
ScienceOn
|
36 |
Hulthe J, Hulten LM, Fagerberg B (2003): Low adipocytederived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 52(12): 1612-1614
DOI
ScienceOn
|
37 |
Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, MacDonald KG, Dohm GL (2002): Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283(4): 861-865
DOI
|
38 |
Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y (1999): Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38(2): 202-206
DOI
ScienceOn
|
39 |
Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T (2004): Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43(6): 1318-1323
DOI
ScienceOn
|
40 |
Jo HS, Baek YH (2006): Effects of combined exercise and green tea intake on body weight and adiponectin in obese high school children. Korean J Life Science 16(6): 972-977
DOI
|
41 |
Gannage-Yared MH, Khalife S, Semaan M, Fares F, Jambert S, Halaby G (2006): Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 155: 167-176
DOI
ScienceOn
|
42 |
Galic S, Oakhill JS, Steinberg GR (2010): Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316: 129-139
DOI
ScienceOn
|
43 |
Corbetta S, Bulfamante G, Cortelazzi D, Barresi V, Cetin I, Mantovani G, Bondioni S, Beck-Peccoz P, Spada A (2005): Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab 90(4): 2397-2402
DOI
ScienceOn
|
44 |
Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kuschner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M (1999): Recombinant leptin for weight loss in obese and lean adults: a randomized, controllrd, dose-escalation trial. JAMA 282: 1568-1575
DOI
ScienceOn
|
45 |
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000): Plasma concentration of a novel adipose specific protein adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6): 1595-1599
DOI
ScienceOn
|
46 |
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR (1996): Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5): 292-295
DOI
ScienceOn
|
47 |
Diez JJ, Iglesias P (2003): The role of the novel adipocytederived hormone adiponectin in human disease. Eur J Endocrinol 148(3): 293-300
DOI
ScienceOn
|
48 |
Friedewald WT, Levy RI, Fredrickson DS (1972): Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6): 499-502
|
49 |
Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Mohlig M, Pfeiffer AF, Luft FC, Sharma AM (2003): Association between adiponectin and mediators of inflammation in obese women. Diabetes 52(4): 942-947
DOI
ScienceOn
|
50 |
Fasshauer M, Paschke R (2003): Regulation of adipocytokines and insulin resistance. Diabetologia 46(12): 1594-1603
DOI
ScienceOn
|
51 |
Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y (2003): Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16(1):72-75
DOI
ScienceOn
|
52 |
Ahn GH, Kim SH, Yoo EG (2008): The relationship between leptin adiponectin ratio and insulin resistance in healthy children. Korean J Pediatr 51(3): 256-261
DOI
ScienceOn
|
53 |
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006): Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1): 4-12
|
54 |
Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD (2006) : Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol 290(1): 139-144
DOI
|
55 |
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001): The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7(8): 947-953
DOI
ScienceOn
|
56 |
Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH (2004): Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 61(1): 75-80
|
57 |
Clement K, Vaisse C, Lahlou N (1998): A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392(10): 398-401
DOI
|